id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-D-1145-0005,FDA,FDA-2012-D-1145,Draft Guidance for Industry on Enrichment Strategies for Clinical Trials to Support Approval of Human Drugs and Biological Products; Extension of Comment Period,Notice,Extension of Comment Period,2013-02-04T05:00:00Z,2013,2,2013-02-04T05:00:00Z,2013-03-19T03:59:59Z,2013-03-19T02:02:30Z,2013-02293,0,0,09000064811e4dd1